Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
<h4>Background</h4>Increasing the diversity of research participants is an important focus of clinical trials. However, little is known regarding who enrolls as healthy volunteers in Phase I clinical trials, which test the safety and tolerability of investigational new drugs. Despite the...
Guardado en:
Autores principales: | Corey A Kalbaugh, Julianne M Kalbaugh, Lisa McManus, Jill A Fisher |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c0931c9a3ed437cb017785e2c069a62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Volunteer Participation in the Health eHeart Study: A Comparison with the US Population
por: Xiaofan Guo, et al.
Publicado: (2017) -
Randomized cross-over evaluation of investigator gender on pain thresholds in healthy volunteers
por: Sellgren Engskov, Anna, et al.
Publicado: (2021) -
A phase I single-blind clinical trial to evaluate the safety of oil palm phenolics (OPP) supplementation in healthy volunteers
por: Syed Fairus, et al.
Publicado: (2018) -
Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes
por: Annemie Deiteren, et al.
Publicado: (2021) -
Population pharmacokinetics of olprinone in healthy male volunteers
por: Kunisawa T, et al.
Publicado: (2014)